baber/WOPTO huggingface dataset:
Patent AU-2011241172-B2 (AU)
Title: Device and method for handling drill string components and drill rig
Inventor: MILIVOJEVIC MISEL
IPC: E21B25/00
Filed: 2011-04-13
Granted: 2014-11-06
Abstract: A device (1) for handling drill string components (28) for a drill rig (13) includes a slide (3) which is arranged displaceable on a longitudinal guide (2), a grip unit (7) being swingable between a first position for receiving and delivering of drill string components beside the drill rig (13) and a second position for assembling and disassembling of drill string components in the drill rig (13), wherein said grip unit includes rotator means (26,27,29,30) for rotation of a gripped drill string component (28). A rotational actuator (8) being supported by the slide (3) has a rotational axis forming an angle with the length guide (2). A swing unit (4) includes a first link portion (11) which is connected to said rotational axis, a second link portion (12), which is connected to the grip unit (7) and a swing joint portion (10).
Patent AU-2011253539-B2 (AU)
Title: Use of compositions comprising triclopyr butoxyethyl ester for the control of woody plants
Inventor: KEENEY FRANKLIN N
IPC: A01N25/02
Filed: 2011-11-21
Granted: 2012-10-04
Abstract: Triclopyr butoxyethyl ester compositions with a dearomatized aliphatic solvent or a vegetable oil ester as a carrier provide enhanced control of woody vegetation in foliar applications.
Patent AU-2011289862-B2 (AU)
Title: Nano-coating thermal barrier and method for making the same
Inventor: RUSSELL JAMES C
IPC: C03C14/00
Filed: 2011-05-06
Granted: 2014-04-03
Abstract: A coating is adapted to be applied to a substrate for managing the flow of heat traveling through the substrate. The coating comprises an array of metal nano-particles held in a glassy matrix.
Patent AU-2011292178-B2 (AU)
Title: Compositions and methods of use comprising combinations of anti-CD74 antibodies with a therapeutic agent. the therapeutic agent may be attached to the anti-CD74 antibody or may be separately administered, either before, simultaneously with or after the anti-CD74 antibody
Inventor: CHANG CHIEN-HSING
IPC: A61P35/00
Filed: 2011-08-15
Granted: 2016-01-07
Abstract: Disclosed are compositions and methods comprising combinations of anti-CD74 antibodies with a therapeutic agent that is attached to the anti-CD74 antibody or separately administered. Preferably, the therapeutic agent is an antibody that binds to an antigen different from CD74, such as CD19, CD20, CD21, CD22, CD23, CD37, CD40, CD40L, CD52, CD80, IL-6, CXCR4 or HLA-DR. However, the therapeutic agent may an immunomodulator, a cytokine, a toxin or other known therapeutic agent. Preferably, the anti-CD74 antibody is part of a DNL complex. More preferably, combination therapy with the anti-CD74 antibody and therapeutic agent is more effective than antibody alone, therapeutic agent alone, or the combination of unconjugated anti-CD74 antibody and therapeutic agent. Administration of combination induces apoptosis of target cells in diseases in which CD74 is overexpressed, such as solid tumors, B-cell lymphomas or leukemias, autoimmune disease, immune dysfunction disease or diabetes.
Patent AU-2011318325-B2 (AU)
Title: Remotely controllable fluid flow control assembly
Inventor: GRIGSBY TOMMY FRANK
IPC: E21B34/06
Filed: 2011-10-14
Granted: 2014-05-29
Abstract: Fluid flow control assemblies capable of being disposed in a wellbore for hydrocarbon fluid production are described. The fluid flow control assemblies can include valves that are actuated via controls from a component positioned at or near the surface to control direction of fluid flow downhole. Packers can be set, slurry can be circulated to screens, and hydrocarbons can be produced via a single trip through the wellbore.
Patent AU-2011352449-B2 (AU)
Title: Gemcabene and derivatives for treating pancreatitis
Inventor: BISGAIER CHARLES L
IPC: A61K31/19
Filed: 2011-12-22
Granted: 2015-06-18
Abstract: Gemcabene, a carboxyalkylether, is effective in the treatment and prevention of pancreatitis in subjects. The compound can be administered in an effective dose as the free acid, a pharmaceutically acceptable salt, or an ester or pro-drug that is hydrolyzed or otherwise metabolized in situ to gemcabene as the free acid or salt thereof.
Patent AU-2011379369-B2 (AU)
Title: System and method of locating missing nodes in networks
Inventor: CORNWALL MARK K
IPC: H04B7/00
Filed: 2011-12-01
Granted: 2015-08-06
Abstract: Systems and methods of locating missing endpoints in a utility meter network include periodically receiving electronic GPS data including coordinates identifying the physical location of a mobile meter reading device and collecting radio frequency (RF) data transmissions sent by one or more missing endpoints in proximity to the mobile meter reading device. Energy levels associated with the RF data transmissions can be used to determine a signal strength indicator for each transmission. The transmissions are collected while the mobile meter reading device is positioned in at least first and second different locations relative to each missing endpoint. A triangulation procedure is electronically implemented using the GPS coordinates and the signal strength indicator for a given missing endpoint as determined in the at least first and second different locations in order to identify an estimated location for the given missing endpoint, which is provided as electronic output to a user.
Patent AU-2012203175-B2 (AU)
Title: Bottle display apparatus
Inventor: SCHNEIDER THOMAS
IPC: A47F7/28
Filed: 2012-05-30
Granted: 2015-06-11
Abstract: In an embodiment, a bottle holder apparatus comprises an elongated element comprising a first end joined to a first arcuate neck retaining portion, a first arm joined to the first arcuate neck retaining portion and to an arcuate loop, a second arm parallel to the first arm and joining the arcuate loop to a second arcuate neck retaining portion that is aligned with the first arcuate neck retaining portion, and a second end joined to the second arcuate neck retaining portion. 60067-0023 FIG. FIG 2I.
Patent AU-2012207635-B2 (AU)
Title: Devices and methods for photoplethysmographic measurements
Inventor: THAVEEPRUNGSRIPORN VISIT
IPC: A61B5/02
Filed: 2012-01-05
Granted: 2015-07-16
Abstract: An optical measurement device and method of use provides non-invasive physiological measurements from a predetermined location on a body part of a user. The optical measurement device provides an illumination and detection assembly configured to generate and detect light of a predetermined wavelength range in the form of a photoplethysmography (PPG) signal, as well as a pressure detection assembly configured to detect an amount of pressure applied to the measurement device by the user being measured. A feedback unit, such as a portable display device, can be coupled to the measurement device to provide the user with real-time feedback of the detected PPG signal and level of applied pressure so that the user may adjust the amount of applied pressure to improve the quality of the detected PPG signal.
Patent AU-2012231811-B2 (AU)
Title: Electrically controlled mortice lock assembly
Inventor: NEWMAN DONALD JOHN
IPC: E05B47/06
Filed: 2012-03-15
Granted: 2016-10-27
Abstract: This invention relates to a mortice lock assembly (1) including a lock means (39) having a powered actuator (40) that is operable in a failsafe condition or a failsecure condition. The assembly (1) also includes a selector (12) for adjusting the condition of the lock means whereby the selector includes a rotatable member (11) that is rotatable through no more than 360° to adjust the condition of the selector.
Patent AU-2012236881-B2 (AU)
Title: Nutritional compositions having reduced sodium content and methods for making same
Inventor: KOENIG ELIZABETH ANN-CLUBBS
IPC: A23L7/109
Filed: 2012-03-26
Granted: 2014-12-11
Abstract: Nutritional compositions with targeted sodium levels for young children (e.g., ages 1-4 years) are provided. In a general embodiment, the present disclosure provides nutritional compositions having a targeted level of sodium, made from wholesome foods that provide macronutrients and micronutrients needed in a child's daily diet and are developmentally appropriate for this age group. The sodium levels of the nutritional compositions may be less than or equal to about 200 mg per 100 g nutritional composition. Methods of making nutritional compositions with targeted sodium levels while also achieving acceptable product flavors at both pilot and factory levels are also provided. The batching methods may include adding a slurry of ice, cold water and KC1 to a batched product after an initial cooling step and before packaging.
Patent AU-2012305254-B2 (AU)
Title: Enzyme-treated tea extract, and tea beverage
Inventor: YAMASHITA TATSUNORI
IPC: A23F3/10
Filed: 2012-09-07
Granted: 2016-05-19
Abstract: Provided are a tea extract imparting a palatable body, and a tea beverage containing the same. Specifically provided is a tea extract extracted after treating tea leaves using a cellulase exhibiting little contaminating pectinase activity.
Patent AU-2012307530-B2 (AU)
Title: A fast dissolving pharmaceutical composition
Inventor: AHUJA VARINDER
IPC: A61K38/095
Filed: 2012-09-07
Granted: 2016-12-08
Abstract: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises both the polysaccharides levan and inulin.
Patent AU-2012318256-B2 (AU)
Title: Hemostatic composition
Inventor: HEDRICH HANS CHRISTIAN
IPC: A61L24/00
Filed: 2012-10-10
Granted: 2015-10-01
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2013/053753 A2 18 April 2013 (18.04.2013) W I PO I P CT (51) International Patent Classification: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, A61L 24/04 (2006.01) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (21) International Application Number: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, PCT/EP2012/070054 RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (22) International Filing Date: TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, 10 October 2012 (10.10.2012) ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 61/545,939 11 October 2011 (11.10.2011) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fl, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (71) Applicants: BAXTER INTERNATIONAL INC. MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, [US/US]; One Baxter Parkway, Deerfield, Illinois 60015 TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (US). BAXTER HEALTHCARE S.A. [CH/CH]; Thur- ML, MR, NE, SN, TD, TG). gauerstrasse 130, CH-8152 Glattpark (Opfikon) (CH). Declarations under Rule 4.17: (72) Inventors: HEDRICH, Hans Christian; Engerthstrasse - as to applicant's entitlement to applyfor and be granted a 171/18, A-1020 Vienna (AT). HOEFINGHOFF, Joris; patent (Rule 4.17(ii)) Guglgasse 8/2/38, A-1 110 Vienna (AT). ( as to the applicant's entitlement to claim the priority of the -~(74) Agent: SONN & PARTNER PATENTANWALTE; earlier application (Rule 4.1 7(iii)) Riemergasse 14, A-1010 Vienna (AT). -of inventorship (Rule 4.1 7(iv)) (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, Published: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, without international search report and to be republished BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, upon receipt of that report (Rule 48.2(g)) DO, DZ, EC, EE, EG, ES, Fl, GB, GD, GE, GH, GM, GT, (54) Title: HEMOSTATIC COMPOSITION (57) Abstract: The invention discloses a hemostatic composition comprising: a) a biocompatible polymer in particulate form suit able for use in hemostasis, and b) one hydrophilic polymeric component comprising reactive groups.
Patent AU-2012323993-B2 (AU)
Title: Methods for the synthesis of 13C labeled DHA and use as a reference standard
Inventor: KHAN M AMIN
IPC: C07C51/00
Filed: 2012-11-16
Granted: 2016-08-25
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2013/071411 A1 23 May 2013 (23.05.2013) WI PO I P CT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07C 57/03 (2006.01) C07C 51/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 49/00 (2006.01) G01N33/58 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, ) .a BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) International Application Number: DO, DZ, EC, EE, EG, ES, Fl, GB, GD, GE, GH, GM, GT, PCT/CA2012/001053 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 16 November 2012 (16.11.2012) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (25) Filing Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/561,225 17 November 2011 (17.11.2011) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: PHENOMENOME DISCOVERIES INC. GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, [CA/CA]; 204-407 Downey Road, Saskatoon, Saskat- UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, chewan S7N 4L8 (CA). TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (72) Inventors: KHAN, Amin, L.; 16645 Jackson Oaks Drive, EE, ES, Fl, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, Morgan Hill, CA 95037 (US). WOOD, Paul, L.; 515 MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, Shawanee Road, Horrogate, TN 37752 (US). TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, GOODENOWE, Dayan; c/o Phenemenome Discoveries ML, MR, NE, SN, TD, TG). Inc., 204-207 Downey Road, Saskatoon, Saskatchewan, Declarations under Rule 4.17: S7N 4L8 (CA). - as to applicant's entitlement to apply for and be granted a (74) Agents: NEWTON, Trevor et al.; Gowling Lafleur patent (Rule 4.17(ii)) Henderson LLP, 160 Elgin Street, Suite 2600, Ottawa, Ontario KlP 1C3 (CA). Published: with international search report (Art. 21(3)) (54) Title: METHODS FOR THE SYNTHESIS OF 13C LABELED DHA AND USE AS A REFERENCE STANDARD o Formula A (57) Abstract: A method for preparing "C labeled docosahexaenoic acid (DHA) represented by Formula A: The method comprises O the conversion of 2-pentyn-l-ol to "C labeled DHA by reaction with propargyl alcohol, DC labeled propargyl alcohol and methyl pent-4-ynoate. The various steps involved include tosylation, coupling, bromination, selective hydrogenation and ester hydrolysis to obtain the final product.
Patent AU-2012328927-B2 (AU)
Title: NMDA receptor modulators and uses thereof
Inventor: KHAN AMIN M
IPC: C07D403/06
Filed: 2012-10-24
Granted: 2017-06-22
Abstract: Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Patent AU-2012347644-B2 (AU)
Title: Subintimal recanalization with bio-absorbable stent
Inventor: ANDERSON JAMES
IPC: A61F2/958
Filed: 2012-12-07
Granted: 2017-04-20
Abstract: A recanalization catheter assembly for establishing a subintimal pathway around an occlusion in a blood vessel. The recanalization catheter assembly an inflatable balloon structure (20) including a distal anchoring portion (60) configured to expand within a true lumen portion of the blood vessel distal of the occlusion to anchor the recanalization catheter from unintentional movement during expansion of a stent in the subintimal pathway. The expandable stent (40), such as a bioabsorbable stent, may be configured to promote native tissue regrowth around the stent to create a superficial intimal layer along the subintimal pathway.
Patent AU-2013200608-B2 (AU)
Title: Component carrier reel splicing tape
Inventor: ROME PATRICK
IPC: B31F5/06
Filed: 2011-01-25
Granted: 2016-12-15
Abstract: A splicing tape for accurately aligning and joining spliced component carrier reels is disclosed. The flexible splice tape allows the components to remain aligned and picked from a component carrier reel without interruption at the union of a first and second reel. The splice tape with an optional stiffening strip provides a flexible, yet strong connection to prevent back and forth, axial and lateral movement between spliced reels. The detection of the disclosed splice tape facilitates elimination of incorrect and mismatched components during splicing. The splice tape comprises a plastic-type material coated on one side with a pressure-sensitive adhesive composition. A protective paper covers the adhesive composition. The splice tape and protective paper are divided into sections using a staggered slit arrangement. The staggered slit arrangement aids in proper alignment and adhesion of the splice tape to component carrier reels.
Patent AU-2013202104-B2 (AU)
Title: Biomarkers for the treatment of hepatocellular carcinoma
Inventor: KIM MIRAN
IPC: A61K31/00
Filed: 2013-01-11
Granted: 2015-11-26
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2013/106686 Al 18 July 2013 (18.07.2013) WI PO I P CT (51) International Patent Classification: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, GO1N 33/574 (2006.01) DO, DZ, EC, EE, EG, ES, Fl, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (21) International Application Number: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, PCT/US2013/021197 ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (22) International Filing Date: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, 11 January 2013 (11.01.2013) RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (25) Filing Language: English ZM, Zw. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 61/586,672 13 January 2012 (13.01.2012) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (71) Applicant: CELGENE CORPORATION [US/US]; 86 TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Morris Avenue, Summit, NJ 07901 (US). EE, ES, Fl, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, (72) Inventors: KIM, Miran; 39 Digiulio Drive, North Provid- MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, ence, RI 02911 (US). WANDS, Jack, R.; 1040 High Hawk TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Road, East Greenwich, RI 02818 (US). BESEME, Sarah; ML, MR, NE, SN, TD, TG). 257 Highland Avenue, Providence, RI 02906 (US). Published: (74) Agents: INSOGNA, Anthony, M. et al.; Jones Day, 222 - with international search report (Art. 21(3)) East 41st Street, New York, NY 10017-6702 (US). - before the expiration of the time limit for amending the (81) Designated States (unless otherwise indicated, for every claims and to be republished in the event of receipt of kind of national protection available): AE, AG, AL, AM, amendments (Rule 48.2(h)) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (54) Title: BIOMARKERS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA Focus Huh7 DMSO LM DMSO LM N C N C N C N C TCF-4 s Lamin -- Short Isoforms (S) Long isoforms (L) *120 120 0 DMSO 800 "CI so ilk o Focus Huh7 Focus Huh7 (57) Abstract: Provided herein are biomarkers for hepatocellular carcinoma and uses thereof.
Patent AU-2013206294-B2 (AU)
Title: Intake structure for saddle type vehicle
Inventor: TSUTSUI NORIYOSHI
IPC: F02B29/02
Filed: 2013-06-13
Granted: 2015-05-14
Abstract: INTAKE STRUCTURE FOR SADDLE TYPE VEHICLE In an intake structure for a saddle type vehicle (1) which includes an intake system (30) disposed behind an engine (20) supported on a vehicle body frame (10) and a vehicle body cover (40) which covers at least a side of the intake system (30), an inlet (30e) which is open to a side of a vehicle body on the inner side of the vehicle body cover (40) is provided in the intake system (30). Further, a negative pressure formation section (50) is provided at a position of the vehicle body cover (40) at a substantially equal height to that of the inlet (30e) and on the rear side of the vehicle. The negative pressure formation section (50 is configured from a depressed portion (50a) at which a vehicle body cover surface (40rs) is depressed to the inner side of the vehicle body and an opening (50b) positioned in the depressed portion (50a). o - C)*
Patent AU-2013206887-B2 (AU)
Title: Phototherapeutic apparatus for focused UVB radiation and vitamin D synthesis and associated systems and methods
Inventor: MOFFAT WILLIAM A
IPC: A61G10/00
Filed: 2013-01-03
Granted: 2017-10-19
Abstract: The present disclosure is directed to a phototherapeutic apparatus for focused UVB radiation and vitamin D synthesis and associated systems methods. In one embodiment a phototherapeutic apparatus can include a housing at least partially defining an irradiation zone, and an ultraviolet (UV) radiation source carried by the housing. The irradiation zone can be configured to accommodate at least a portion of a human patient. The phototherapeutic apparatus can further include a filter between the UV radiation source and the irradiation zone. The filter can be configured to at least substantially remove UV radiation outside of a predetermined spectrum centered at about 297 nm and having a bandwidth of at most 10 nm.
Patent AU-2013215165-B2 (AU)
Title: Dual gradient managed pressure drilling
Inventor: FEASEY GUY F
IPC: E21B21/08
Filed: 2013-01-30
Granted: 2017-03-30
Abstract: A method of drilling a subsea wellbore includes drilling the wellbore by injecting drilling fluid through a tubular string extending into the wellbore from an offshore drilling unit (ODU) and rotating a drill bit disposed on a bottom of the tubular string. The method further includes, while drilling the wellbore: mixing lifting fluid with drilling returns at a flow rate proportionate to a flow rate of the drilling fluid, thereby forming a return mixture. The lifting fluid has a density substantially less than a density of the drilling fluid. The return mixture has a density substantially less than the drilling fluid density. The method further includes, while drilling the wellbore: measuring a flow rate of the returns or the return mixture; and comparing the measured flow rate to the drilling fluid flow rate to ensure control of a formation being drilled.
Patent AU-2013220156-B2 (AU)
Title: Aptamer method
Inventor: TURNER DANIEL JOHN
IPC: G01N33/53
Filed: 2013-02-14
Granted: 2018-08-09
Abstract: The invention relates to a new method of determining in a sample the presence or absence of one or more analyte members of a group of two or more analytes. The invention therefore relates to a multiplex assay for determining the presence or absence of each analyte in a group of multiple analytes. The assay uses aptamers and transmembrane pores.